The apoptotic death of neuroblastoma cells caused by serum from patients with insulin-dependent diabetes and neuropathy may be Fas-mediated
- 1 June 1997
- journal article
- research article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 76 (1-2) , 153-160
- https://doi.org/10.1016/s0165-5728(97)00042-8
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- A role for CD95 ligand in preventing graft rejectionNature, 1995
- Beneficial effect of the Ca2+ antagonist, nimodipine, on existing diabetic neuropathy in the BB/Wor ratBritish Journal of Pharmacology, 1994
- Amyotrophic lateral sclerosis patient antibodies label Ca2+ channel α1 subunitAnnals of Neurology, 1994
- Genetic analysis of immune dysfunction in non‐obese diabetic (NOD) mice: Mapping of a susceptibility locus close to the Bcl‐2 gene correlates with increased resistance of NOD T cells to apoptosis inductionEuropean Journal of Immunology, 1994
- Diabetic neuropathy, nerve growth factor and other neurotrophic factorsTrends in Neurosciences, 1994
- Apoptosis and diseaseThe Lancet, 1993
- Prevention of Programmed Cell Death of Sympathetic Neurons by the bcl-2 Proto-OncogeneScience, 1992
- Different Effects of Duration on Prevalence of Anti-Adrenal Medullary and Pancreatic Islet Cell Antibodies in Type I Diabetes MellitusHormone and Metabolic Research, 1989
- Report and Recommendations of the San Antonio Conference on Diabetic NeuropathyDiabetes Care, 1988
- The Prevalence of Symptomatic, Diabetic Neuropathy in an Insulin-treated PopulationDiabetes Care, 1985